Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marschner

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humansK Farker, L Henschel, J P Marschner, et al.
Die Pharmazie|May 1, 1993
[The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)]K Farker, L Henschel, J P Marschner, et al.
Environmental Pollution (Barking, Essex : 1987)|January 18, 2006
The veterinary antibiotic oxytetracycline and Cu influence functional diversity of the soil microbial communityW-D Kong, Y-G Zhu, B-J Fu, et al.
Die Pharmazie|May 1, 1993
[Hemodynamic effects and adverse effects of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, G Dannberg, H Kühnert, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
Absorption behavior of sulpiride described using Weibull functionsS Rietbrock, P G Merz, U Fuhr, et al.
Die Pharmazie|May 1, 1993
[Clinical-electrophysiologic studies on the actions of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, A Hoffmann, H Kühnert, et al.
Liver|June 26, 2001
Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsA B van Nunen, M Baumann, M P Manns, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1992
Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humansK Farker, L Henschel, J P Marschner, et al.
Die Pharmazie|May 1, 1993
[The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)]K Farker, L Henschel, J P Marschner, et al.
Environmental Pollution (Barking, Essex : 1987)|January 18, 2006
The veterinary antibiotic oxytetracycline and Cu influence functional diversity of the soil microbial communityW-D Kong, Y-G Zhu, B-J Fu, et al.
Die Pharmazie|May 1, 1993
[Hemodynamic effects and adverse effects of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, G Dannberg, H Kühnert, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
Absorption behavior of sulpiride described using Weibull functionsS Rietbrock, P G Merz, U Fuhr, et al.
Die Pharmazie|May 1, 1993
[Clinical-electrophysiologic studies on the actions of the anti-arrhythmic substance AWD-G256 in man]H Volkmann, A Hoffmann, H Kühnert, et al.
Liver|June 26, 2001
Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsA B van Nunen, M Baumann, M P Manns, et al.
Pageof 2